Literature DB >> 19259624

Tumor stroma derived biomarkers in cancer.

Malin Sund1, Raghu Kalluri.   

Abstract

In recent years the importance of the tumor stroma for the development, promotion and invasion of cancer is becoming increasingly clear. Besides a malignantly transformed cancer cell, tumors also contains many other cell types, including endothelial cells, fibroblasts and cells of the immune system. These cells together with the cancer cells produce the sum extracellular matrix (ECM) of the tumor. The ECM and the non-malignant cells of the tumor are defined as the "tumor stroma". Just as the malignant cell itself can be the source of substances that can be used as biomarkers of cancer, the tumor stroma contains factors that potentially can be used as biomarkers when treating patients with cancer. In this review we will discuss the role of the tumor stroma as a source of new cancer biomarkers. This concept highlights a novel view of cancer and treats them as organized organs. Additionally, this further stresses the importance of including factors related to the tumor stroma into the diagnostic and therapeutic equation of cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259624      PMCID: PMC4476244          DOI: 10.1007/s10555-008-9175-2

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  56 in total

1.  Distinct epigenetic changes in the stromal cells of breast cancers.

Authors:  Min Hu; Jun Yao; Li Cai; Kurt E Bachman; Frédéric van den Brûle; Victor Velculescu; Kornelia Polyak
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

2.  Tumstatin, an endothelial cell-specific inhibitor of protein synthesis.

Authors:  Yohei Maeshima; Akulapalli Sudhakar; Julie C Lively; Kohjiro Ueki; Surender Kharbanda; C Ronald Kahn; Nahum Sonenberg; Richard O Hynes; Raghu Kalluri
Journal:  Science       Date:  2002-01-04       Impact factor: 47.728

3.  Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer.

Authors:  T Kato; S Kameoka; T Kimura; N Soga; Y Abe; T Nishikawa; M Kobayashi
Journal:  Breast Cancer Res Treat       Date:  2001-11       Impact factor: 4.872

4.  Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection.

Authors:  Long Sun; Huang-Yang Ye; Ying-Hong Zhang; Yong-Song Guan; Hua Wu
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

5.  Expression pattern and circulating levels of endostatin in patients with pancreas cancer.

Authors:  Daniel Ohlund; Bjarne Ardnor; Mikael Oman; Peter Naredi; Malin Sund
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer.

Authors:  Theresa Casey; Jeffrey Bond; Scott Tighe; Timothy Hunter; Laura Lintault; Osman Patel; Jonathan Eneman; Abigail Crocker; Jeffrey White; Joseph Tessitore; Mary Stanley; Seth Harlow; Donald Weaver; Hyman Muss; Karen Plaut
Journal:  Breast Cancer Res Treat       Date:  2008-03-29       Impact factor: 4.872

9.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up.

Authors:  S E Pinder; I O Ellis; M Galea; S O'Rouke; R W Blamey; C W Elston
Journal:  Histopathology       Date:  1994-01       Impact factor: 5.087

10.  Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.

Authors:  Yun Ling; Yong Yang; Na Lu; Qi-dong You; Sen Wang; Ying Gao; Yan Chen; Qing-Long Guo
Journal:  Biochem Biophys Res Commun       Date:  2007-07-10       Impact factor: 3.575

View more
  54 in total

Review 1.  Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors.

Authors:  Edna Cukierman; Daniel E Bassi
Journal:  Semin Cancer Biol       Date:  2010-05-07       Impact factor: 15.707

2.  Integration of biological knowledge and gene expression data for biomarker selection: FN1 as a potential predictor of radiation resistance in head and neck cancer.

Authors:  Sally A Amundson; Lubomir B Smilenov
Journal:  Cancer Biol Ther       Date:  2010-12-15       Impact factor: 4.742

Review 3.  Advances in the role of exosomal non-coding RNA in the development, diagnosis, and treatment of gastric cancer (Review).

Authors:  Peng-Fei Gao; Da Huang; Jun-Yan Wen; Wei Liu; Hong-Wu Zhang
Journal:  Mol Clin Oncol       Date:  2020-06-10

Review 4.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment.

Authors:  Maurizio Mongiat; Stefano Marastoni; Giovanni Ligresti; Erica Lorenzon; Monica Schiappacassi; Roberto Perris; Sergio Frustaci; Alfonso Colombatti
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

6.  Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals.

Authors:  Xiaohai Wang; Soo Ok Lee; Shujie Xia; Qi Jiang; Jie Luo; Lei Li; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2013-03-27       Impact factor: 6.261

7.  Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.

Authors:  Elin Hadler-Olsen; Hilde Ljones Wetting; Oddveig Rikardsen; Sonja E Steigen; Premasany Kanapathippillai; Reidar Grénman; Jan-Olof Winberg; Gunbjørg Svineng; Lars Uhlin-Hansen
Journal:  Virchows Arch       Date:  2010-10-03       Impact factor: 4.064

8.  Interstitial fluid: the overlooked component of the tumor microenvironment?

Authors:  Helge Wiig; Olav Tenstad; Per Ole Iversen; Raghu Kalluri; Rolf Bjerkvig
Journal:  Fibrogenesis Tissue Repair       Date:  2010-07-23

Review 9.  Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer.

Authors:  Mohammad Rahbari; Nuh Rahbari; Christoph Reissfelder; Juergen Weitz; Christoph Kahlert
Journal:  Langenbecks Arch Surg       Date:  2016-06-24       Impact factor: 3.445

10.  Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.

Authors:  Dong Tang; Jun Gao; Sen Wang; Nianyuan Ye; Yang Chong; Yuqin Huang; Jie Wang; Bin Li; Wei Yin; Daorong Wang
Journal:  Tumour Biol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.